Merck & Co. investing in Irish plant to support Keytruda supply
Merck & Co. will invest €11.5m ($12.5m) at a plant in Ireland to manufacture its oncology drug Keytruda, an anti-PD1 mAb recently approved by the US FDA.
Archives for April 23, 2015
Measuring mAbs with magnetic resonance can help regulatory testing
US researchers have discovered the most precise method yet for measuring the structure of monoclonal antibodies. The technique gives manufacturers and regulators a way of assessing and comparing the performance and quality of mAbs using nuclear...
Bio-CMO sector to grow over 40% on Big Biopharma's burgeoning pipelines
Cheaper disposable manufacturing techs and increased demand for outsourced production will see more CMOs enter the contracting sector according to HighTech Business Decisions